Nadolol and bendroflumethiazide vs Calcium Channel Blockers (Dihydropyridine)

Interacting Drugs
Nadolol and bendroflumethiazide
vs
Calcium Channel Blockers (Dihydropyridine)
Security Level
Minor, Monitor Therapy
Mechanism
Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Nadolol and bendroflumethiazide vs Calcium Channel Blockers (Dihydropyridine)